The Clinical Spectrum of Alzheimer’s Disease The Charge Toward Comprehensive Diagnostic and Therapeutic Strategies

preface_ The Clinical Spectrum of Alzheimer’s Disease-The Charge......Page 1
Part 1......Page 15
01_Risk Factors for Disease Progression in
Alzheimer's Disease......Page 17
02_Alzheimer’s Disease Genomics
and Clinical Applications......Page 35
03_Addressing Risk Factors for Neurocognitive
Decline and Alzheimer’s Disease Among African
Americans in the Era of Health Disparities......Page 57
Part 2......Page 75
04_Focal Cortical Presentations
Genetically Proven Alzheimer Disease......Page 77
05_Spatial Navigation Impairment in Healthy
Aging and Alzheimer’s Disease......Page 89
06_Visual Cognition in Alzheimer’s Disease and
Its Functional Implications......Page 115
07_Olfactory Dysfunctions in Alzheimer’s Disease......Page 141
Part 3......Page 159
08_Currently Available Neuroimaging Approaches
in Alzheimer Disease (AD) Early Diagnosis......Page 161
09_The Clinical Use of SPECT and PET Molecular
Imaging in Alzheimer’s Disease......Page 195
Part 4......Page 219
10_Cerebrospinal Fluid Based Diagnosis in
Alzheimer’s Disease......Page 221
11_Alzheimer’s Diseases: Towards
Biomarkers for an Early Diagnosis......Page 235
12_Phospo-PKCs in Abeta1-42-Specific Human
T Cells from Alzheimer’s Disease Patients......Page 257
13_The Predictive Role of Hyposmia in
Alzheimer's Disease......Page 273
14_Retinal Nerve Fibre Layer
Thinning in Alzheimer Disease......Page 293
Part 5......Page 309
15_Modulation of Signal Transduction Pathways in
Senescence-Accelerated Mice P8 Strain:
A Useful Tool for Alzheimer’s Disease Research......Page 311
16_Valosin-Containing Protein (VCP) Disease
and Familial Alzheimer’s Disease:
Contrasts and Overlaps......Page 345
17_Neural Basis of Hyposmia in
Alzheimer’s Disease......Page 361